These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17852836)

  • 21. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes.
    Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Hussain T
    Mol Biol Rep; 2011 Aug; 38(6):3703-8. PubMed ID: 21400095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion.
    Johansen A; Nielsen EM; Andersen G; Hamid YH; Jensen DP; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Diabetologia; 2004 Aug; 47(8):1437-41. PubMed ID: 15258737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strong interaction between T allele of endothelial nitric oxide synthase with B1 allele of cholesteryl ester transfer protein TaqIB highly elevates the risk of coronary artery disease and type 2 diabetes mellitus.
    Rahimi Z; Nourozi-Rad R; Rahimi Z; Parsian A
    Hum Genomics; 2012 Sep; 6(1):20. PubMed ID: 23157875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants of serum butyrylcholinesterase in Chilean Mapuche Indians.
    Acuña M; Eaton L; Ramírez NR; Cifuentes L; Llop E
    Am J Phys Anthropol; 2003 May; 121(1):81-5. PubMed ID: 12687586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease.
    Masoudi-Kazemabad A; Jamialahmadi K; Moohebati M; Mojarrad M; Dehghan-Manshadi R; Forghanifard MM; Akhlaghi S; Ferns GA; Ghayour-Mobarhan M
    Gene; 2012 Mar; 496(1):22-7. PubMed ID: 22289186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association of interleukin-1 gene cluster polymorphisms with angiographically documented coronary artery disease: demonstration of association with hypertension in the Polish population.
    Gorący J; Gorący I; Safranow K; Taryma O; Adler G; Ciechanowicz A
    Arch Med Res; 2011 Jul; 42(5):426-32. PubMed ID: 21840356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
    Combarros O; Riancho JA; Infante J; Sañudo C; Llorca J; Zarrabeitia MT; Berciano J
    Dement Geriatr Cogn Disord; 2005; 20(2-3):153-7. PubMed ID: 16020944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress.
    Rahimi Z; Ahmadi R; Vaisi-Raygani A; Rahimi Z; Bahrehmand F; Parsian A
    J Matern Fetal Neonatal Med; 2013 Nov; 26(16):1590-4. PubMed ID: 23650977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. -116A and K BCHE gene variants associated with obesity and hypertriglyceridemia in adolescents from Southern Brazil.
    Chaves TJ; Leite N; Milano GE; Milano GE; Souza RL; Chautard-Freire-Maia EA; Furtado-Alle L
    Chem Biol Interact; 2013 Mar; 203(1):341-3. PubMed ID: 23000450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population.
    Mathew J; Narayanan P; Sundaram R; Jayaraman B; Dutta TK; Raman SK; Chandrasekaran A
    Indian Heart J; 2008; 60(3):223-7. PubMed ID: 19240311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
    Maetzler W; Keller S; Michelis J; Koehler N; Stransky E; Becker C; Schulte C; Melms A; Gasser T; Berg D
    Neurobiol Dis; 2009 Aug; 35(2):296-301. PubMed ID: 19481150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis.
    Szperl M; Dzielinska Z; Roszczynko M; Malek LA; Makowiecka-Ciesla M; Demkow M; Kadziela J; Prejbisz A; Florczak E; Zielinski T; Januszewicz A; Ruzyllo W
    Med Sci Monit; 2008 Dec; 14(12):CR611-6. PubMed ID: 19043368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.
    Shenhar-Tsarfaty S; Bruck T; Bennett ER; Bravman T; Aassayag EB; Waiskopf N; Rogowski O; Bornstein N; Berliner S; Soreq H
    J Cell Mol Med; 2011 Aug; 15(8):1747-56. PubMed ID: 20807286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients.
    Pongthanaracht N; Yanarojana S; Pinthong D; Unchern S; Thithapandha A; Assantachai P; Supavilai P
    Clin Interv Aging; 2017; 12():897-901. PubMed ID: 28603409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
    Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
    Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.